As CEO of Solid Biosciences Inc., Alexander Cumbo holds a substantial stake in the company, showcasing his confidence in its future. His insider trading records reveal fluctuations in stock sales, notably peaking at $8.09 million in July 2020 before settling...

As CEO of Solid Biosciences Inc., Alexander Cumbo holds a substantial stake in the company, showcasing his confidence in its future. His insider trading records reveal fluctuations in stock sales, notably peaking at $8.09 million in July 2020 before settling lower in recent months. His wealth in company holdings has varied, with notable sales reflecting a mix of strategy and market timing. For instance, in 2023 alone, his stocks were valued at around $6.79 million in June before dropping to $4.32 million by November, showing his active engagement with the company’s performance. These shifts illustrate Cumbo's keen awareness of market dynamics while maintaining a substantial interest in Solid Biosciences through his vested stock awards, which were worth approximately $200,000 in 2023. This engagement underscores both his personal commitment and financial tie to the company’s direction and success.